The present invention relates to a 5-(1,3-diaryl-1H-pyrazol-4-ylmethylene)-thiazolidine-2,4-dione derivative or its pharmaceutically acceptable salts thereof, a method for preparing the same and an anticancer agent composition comprising the same as an active ingredient.

 
Web www.patentalert.com

< Promoters having a modified transcription efficiency and derived from methyltrophic yeast

< Triterpenic acid derivative and preparation for external application for skin comprising the same

> Anhydrous zinc antimonate sol and process for producing same

> Organic silicon-based compound and method of producing the same
~ 00609